Home › Osteosarcoma › Ohio
Pag-aaral pangklinika para sa Osteosarcoma sa Ohio
12 pag-aaral para sa Osteosarcoma ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT04616560Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 1/2
Edad 12 hanggang 40 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07725380Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- at 4 pa
Nagre-recruitPhase 3
Hanggang edad 50 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05235165SPEARHEAD-3 Pediatric Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455Musculoskeletal Cancers Remote Monitoring and Care
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07129226Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05210374NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06239272Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Nagre-recruit
Edad 13 pataas · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT06387485A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 2
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
- UH Rainbow Babies & Children's Hospital, Cleveland
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Abr 10, 2025 · NCT05588648Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.